ALUMIS INC.

From the company

Transform Therapies, Reimagine Lives Our Mission Transform treatment for immune-mediated diseases, empower people to reimagine their lives. About Alumis Our Programs We are advancing a late-stage portfolio of next-generation targeted therapies to optimize patient outcomes across a wide range of immune-mediated diseases. PIPELINE Our Approach Our precision approach builds on integrated scientific insights – powered by our proprietary data analytics platform – to drive smarter therapeutic development. science Our Culture We foster a culture where teams elevate, challenge, and nurture each other, living our values while driving our mission forward. careers News October 9, 2026 Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures September 4, 2026 Alumis to Participate in Upcoming.